This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rahme, M. M. Articles by Feld, G. K. Search for Related Content PubMed PubMed Citation Articles by Rahme, M. M. Articles by Feld, G. K. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

Electrophysiologic and Antiarrhythmic Effects of the New Class III Antiarrhythmic Drug KCB-328 in Experimental Canine Atrial Flutter

GilAnthony Ungab, MD

Manish Wadhwa, MD

Fawziah Al-Kandari, MD

Biguang Yao, MD

Anuj Gupta, BSc

Cardiac Electrophysiology Program, Division of Cardiology, Department of Medicine, University of California, San Diego

Kiho Lee, DVM

Hak-Yeop Kim, PhD

C&C Research Labs, Republic of Korea

Gregory K. Feld, MD

Cardiac Electrophysiology Program, Division of Cardiology, Department of Medicine, University of California, San Diego

Background: The electrophysiologic and antiarrhythmic effects of a new class III antiarrhythmic drug (KCB-328), a delayed rectifier potassium current (IKr) blocker with minimal reverse use-dependent effect on atrial repolarization, were evaluated in the canine night atrial crush-injury model of atrial flutter (AFL).

Methods: Ten anesthetized, open-chest dogs, were studied after right atrial crush-injury. Atrial effective refractory period (ERP), conduction velocity (CV), wavelength, and dispersion of refractoriness were determined during programmed stimulation (S1S2 at SISI = 200, 300, 400, and 500 msec) at four sites via a mapping plaque sutured on the right atrial free wall. Right and left ventricular ERP were similarly measured at single sites. Electrophysiological parameters were determined at baseline and following sequential cumulative doses of KCB-328 (10, 30, 100. and 300,ug/kg).

Results: Sustained AFL was inducible in 7/10 dogs by rapid pacing following baseline electrophysiologic measurements. KCB-328 significantly prolonged sinus cycle length, but had no effect on PR interval, and prolonged QTc only at the highest dose level. KCB-328 significantly prolonged atrial ERP and wavelength and ventricular ERP, and significantly reduced dispersion of atrial refractoriness. KCB-328 significantly prolonged AFL cycle length, and increasing doses progressively terminated sustained AFL and prevented its reinduction by pacing. No adverse hemodynamic or ventricular proarrhythmic effects were observed.

Conclusions: The electrophysiologic profile of KCB-328 in this canine model of AFL, particularly its lack of reverse use-dependent effect on atrial refractoriness, suggests that it may have significant antiarrhythmic potential in treatment of atrial arrhythmias.

Key Words: atrial flutter • class III antiarrhythmic • KCB-328 • electrophysiology • atrial refractoriness

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 6, No. 3, 297-306 (2001)
DOI: 10.1177/107424840100600310


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. Chandra, T. S. Rosen, Z.-H. Yeom, K. Lee, H.-Y. Kim, P. Danilo Jr, and M. R. Rosen Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation Europace, January 1, 2004; 6(5): 384 - 391. [Abstract] [Full Text] [PDF]